|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-12-7
|
|
pubmed:abstractText |
This study was a real-world, retrospective evaluation of the clinical effectiveness of switching to continuous subcutaneous insulin infusion (CSII) among managed care enrollees with type 2 diabetes for whom multiple daily injections (MDI) had presumably failed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1751-9918
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
209-14
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20832374-Adolescent,
pubmed-meshheading:20832374-Adult,
pubmed-meshheading:20832374-Aged,
pubmed-meshheading:20832374-Blood Glucose,
pubmed-meshheading:20832374-Chi-Square Distribution,
pubmed-meshheading:20832374-Diabetes Mellitus, Type 2,
pubmed-meshheading:20832374-Drug Administration Schedule,
pubmed-meshheading:20832374-Female,
pubmed-meshheading:20832374-Hemoglobin A, Glycosylated,
pubmed-meshheading:20832374-Humans,
pubmed-meshheading:20832374-Hypoglycemia,
pubmed-meshheading:20832374-Hypoglycemic Agents,
pubmed-meshheading:20832374-Infusions, Subcutaneous,
pubmed-meshheading:20832374-Injections, Subcutaneous,
pubmed-meshheading:20832374-Insulin,
pubmed-meshheading:20832374-Insulin Infusion Systems,
pubmed-meshheading:20832374-Male,
pubmed-meshheading:20832374-Managed Care Programs,
pubmed-meshheading:20832374-Middle Aged,
pubmed-meshheading:20832374-Retrospective Studies,
pubmed-meshheading:20832374-Severity of Illness Index,
pubmed-meshheading:20832374-Time Factors,
pubmed-meshheading:20832374-Treatment Outcome,
pubmed-meshheading:20832374-United States,
pubmed-meshheading:20832374-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis.
|
|
pubmed:affiliation |
Medtronic, Inc., Northridge, CA 91325, USA. peter.m.lynch@medtronic.com
|
|
pubmed:publicationType |
Journal Article
|
